BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 17240304)

  • 21. Tyrosine kinase mutations in gastrointestinal stromal tumors in a nation-wide study in Iceland.
    Tryggvason G; Hilmarsdottir B; Gunnarsson GH; Jónsson JJ; Jónasson JG; Magnússon MK
    APMIS; 2010 Sep; 118(9):648-56. PubMed ID: 20718716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor alpha activating mutations in gastrointestinal stromal tumors.
    Holden JA; Willmore-Payne C; Coppola D; Garrett CR; Layfield LJ
    Am J Clin Pathol; 2007 Aug; 128(2):230-8. PubMed ID: 17638656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors.
    Ogino J; Asanuma H; Sakurai S; Matsuno Y; Miyokawa N; Yamashiro K; Fukazawa Y; Muraoka S; Iwaki Y; Kondo N; Hasegawa T
    Pathol Int; 2010 Nov; 60(11):707-13. PubMed ID: 20946519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.
    Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM
    Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations.
    Kang HJ; Koh KH; Yang E; You KT; Kim HJ; Paik YK; Kim H
    Proteomics; 2006 Feb; 6(4):1151-7. PubMed ID: 16402362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
    Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
    Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
    Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status.
    Wozniak A; Sciot R; Guillou L; Pauwels P; Wasag B; Stul M; Vermeesch JR; Vandenberghe P; Limon J; Debiec-Rychter M
    Genes Chromosomes Cancer; 2007 Mar; 46(3):261-76. PubMed ID: 17171690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.
    Sápi Z; Füle T; Hajdu M; Matolcsy A; Moskovszky L; Márk A; Sebestyén A; Bodoky G
    Diagn Mol Pathol; 2011 Mar; 20(1):22-33. PubMed ID: 21326036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and pathologic characteristics of gastrointestinal stromal tumors in extragastric lesions.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Mol Med; 2006 Dec; 18(6):1067-71. PubMed ID: 17089009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
    Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
    J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal stromal tumor in Brazil: clinicopathology, immunohistochemistry, and molecular genetics of 513 cases.
    Lopes LF; Ojopi EB; Bacchi CE
    Pathol Int; 2008 Jun; 58(6):344-52. PubMed ID: 18477213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A gastrointestinal stromal tumor of the stomach morphologically resembling a neurofibroma: demonstration of a novel platelet-derived growth factor receptor alpha exon 18 mutation.
    Liu T; Willmore-Payne C; Layfield LJ; Glasgow RE; Holden JA
    Hum Pathol; 2008 Dec; 39(12):1849-53. PubMed ID: 18657298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of c-KIT and PDGFRA gene mutations in gastrointestinal stromal tumors: comparison of DHPLC and DNA sequencing methods using a single population-based cohort.
    Battochio A; Mohammed S; Winthrop D; Lefresne S; Mulder K; Chu Q; O'Hara C; Lai R
    Am J Clin Pathol; 2010 Jan; 133(1):149-55. PubMed ID: 20023271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary gastrointestinal stromal tumor of the liver with PDGFRA gene mutation.
    Yamamoto H; Miyamoto Y; Nishihara Y; Kojima A; Imamura M; Kishikawa K; Takase Y; Ario K; Oda Y; Tsuneyoshi M
    Hum Pathol; 2010 Apr; 41(4):605-9. PubMed ID: 20096441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational status of KIT and PDGFRA and expression of PDGFRA are not associated with prognosis after curative resection of primary gastrointestinal stromal tumors (GISTs).
    Kern A; Görgens H; Dittert DD; Krüger S; Richter KK; Schackert HK; Saeger HD; Baretton G; Pistorius S
    J Surg Oncol; 2011 Jul; 104(1):59-65. PubMed ID: 21387320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.
    Miselli FC; Casieri P; Negri T; Orsenigo M; Lagonigro MS; Gronchi A; Fiore M; Casali PG; Bertulli R; Carbone A; Pierotti MA; Tamborini E; Pilotti S
    Clin Cancer Res; 2007 Apr; 13(8):2369-77. PubMed ID: 17438095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutants.
    Lasota J; Kuban W; Wardelmann E; Debiec-Rychter M; Merkelbach-Bruse S; Sciot R; Rys J; Steigen SE; Iwanik K; Holden JA; Jerzak Vel Dobosz A; Schildhaus HU; Miettinen M
    Hum Pathol; 2008 Dec; 39(12):1728-36. PubMed ID: 18715619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.